|
🐜
|
The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort
169 auth.
K. Marek,
S. Chowdhury,
A. Siderowf,
Shirley Lasch,
C. Coffey,
C. Caspell-Garcia,
T. Simuni,
D. Jennings,
C. Tanner,
J. Trojanowski,
L. Shaw,
J. Seibyl,
N. Schuff,
A. Singleton,
K. Kieburtz,
...
A. Toga,
B. Mollenhauer,
D. Galasko,
L. Chahine,
D. Weintraub,
T. Foroud,
D. Tosun-Turgut,
K. Poston,
V. Arnedo,
M. Frasier,
T. Sherer,
S. Bressman,
M. Merchant,
W. Poewe,
C. Kopil,
A. Naito,
R. Dorsey,
C. Casaceli,
N. Daegele,
J. Albani,
L. Uribe,
Eric D. Foster,
J. Long,
N. Seedorff,
K. Crawford,
Danielle Smith,
P. Casalin,
G. Malferrari,
C. Halter,
L. Heathers,
D. Russell,
S. Factor,
P. Hogarth,
A. Amara,
R. Hauser,
J. Jankovic,
M. Stern,
Shu‐Ching Hu,
Gretchen Todd,
R. Saunders-Pullman,
I. Richard,
H. Saint‐Hilaire,
K. Seppi,
H. Shill,
Hubert H. Fernandez,
C. Trenkwalder,
W. Oertel,
D. Berg,
Kathrin Brockman,
I. Wurster,
L. Rosenthal,
Yen F. Tai,
N. Pavese,
P. Barone,
S. Isaacson,
A. Espay,
D. Rowe,
M. Brandabur,
J. Tetrud,
G. Liang,
Á. Iranzo,
E. Tolosa,
K. Marder,
Maria de Sanchez,
L. Stefanis,
M. Marti,
J. Martínez,
J. Corvol,
O. Assly,
Salima Brillman,
Nir Giladi,
Debra Smejdir,
Julia Pelaggi,
F. Kausar,
L. Rees,
Barbara Sommerfield,
Madeline Cresswell,
C. Blair,
Karen Williams,
Grace A. Zimmerman,
S. Guthrie,
Ashlee Rawlins,
Leigh Donharl,
C. Hunter,
B. Tran,
A. Darin,
Heli A. Venkov,
Cathi A Thomas,
Raymond James,
B. Heim,
Paul Deritis,
F. Sprenger,
D. Raymond,
D. Willeke,
Zoran Obradov,
J. Mule,
Nancy Monahan,
K. Gauss,
D. Fontaine,
D. Szpak,
Arita McCoy,
Becky Dunlop,
Laura Payne,
Susan Ainscough,
L. Carvajal,
Rebecca Silverstein,
Kristy J. Espay,
Madelaine B. Rañola,
E. Rezola,
H. Santana,
M. Stamelou,
Alicia Garrido,
S. Carvalho,
G. Kristiansen,
Krista Specketer,
Anat Mirlman,
M. Facheris,
H. Soares,
A. Mintun,
J. Cedarbaum,
Peggy Taylor,
L. Slieker,
Brian McBride,
Colin Watson,
Etienne Montagut,
Z. Sheikh,
Baris Bingol,
R. Forrat,
P. Sardi,
T. Fischer,
D. Reith,
J. Egebjerg,
L. Larsen,
N. Breysse,
D. Meulien,
B. Saba,
V. Kiyasova,
C. Min,
Thomas McAvoy,
R. Umek,
P. Iredale,
J. Edgerton,
Demetrio Santi,
C. Czech,
F. Boess,
J. Sevigny,
T. Kremer,
I. Grachev,
K. Merchant,
A. Avbersek,
P. Muglia,
Alexandra Stewart,
R. Prashad,
Johannes Taucher
|
8 |
2018 |
8
🐜
|
|
🐜
|
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease
18 auth.
D. Weintraub,
T. Simuni,
C. Caspell-Garcia,
C. Coffey,
Shirley Lasch,
A. Siderowf,
D. Aarsland,
P. Barone,
D. Burn,
L. Chahine,
...
J. Eberling,
A. Espay,
Eric D. Foster,
J. Leverenz,
I. Litvan,
I. Richard,
M. Troyer,
K. Hawkins
|
8 |
2015 |
8
🐜
|
|
🐜
|
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study
30 auth.
A. Siderowf,
L. Concha-Marambio,
David-Erick Lafontant,
C. Farris,
Yihua Ma,
P. A. Urenia,
Hieu Nguyen,
R. Alcalay,
L. Chahine,
T. Foroud,
Douglas Galasko,
K. Kieburtz,
Kalpana M. Merchant,
B. Mollenhauer,
K. Poston,
...
J. Seibyl,
T. Simuni,
C. Tanner,
D. Weintraub,
A. Videnovic,
Seung Ho Choi,
R. Kurth,
C. Caspell-Garcia,
C. Coffey,
M. Frasier,
L. M. Oliveira,
S. Hutten,
T. Sherer,
K. Marek,
C. Soto
|
7 |
2023 |
7
🐜
|
|
🐜
|
CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study
27 auth.
Ju-Hee Kang,
B. Mollenhauer,
C. Coffey,
J. Toledo,
D. Weintraub,
D. Galasko,
D. Irwin,
V. V. Van Deerlin,
A. Chen-Plotkin,
C. Caspell-Garcia,
T. Waligórska,
Peggy Taylor,
Nirali Shah,
Sarah Pan,
Paweł Żero,
...
M. Frasier,
K. Marek,
K. Kieburtz,
D. Jennings,
C. Tanner,
T. Simuni,
A. Singleton,
A. Toga,
S. Chowdhury,
J. Trojanowski,
L. Shaw,
The Initiative
|
7 |
2016 |
7
🐜
|
|
🐜
|
Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort
26 auth.
T. Simuni,
A. Siderowf,
Shirley Lasch,
C. Coffey,
C. Caspell-Garcia,
D. Jennings,
C. Tanner,
J. Trojanowski,
L. Shaw,
J. Seibyl,
N. Schuff,
A. Singleton,
K. Kieburtz,
A. Toga,
B. Mollenhauer,
...
D. Galasko,
L. Chahine,
D. Weintraub,
T. Foroud,
D. Tosun,
K. Poston,
V. Arnedo,
M. Frasier,
T. Sherer,
S. Chowdhury,
K. Marek
|
7 |
2018 |
7
🐜
|
|
🐬
|
How stable are Parkinson's disease subtypes in de novo patients: Analysis of the PPMI cohort?
T. Simuni,
C. Caspell-Garcia,
C. Coffey,
Shirley Lasch,
C. Tanner,
K. Marek
|
7 |
2016 |
7
🐬
|
|
🐜
|
High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease
18 auth.
Marco J. Russo,
C. Orrú,
L. Concha-Marambio,
Simone Giaisi,
B. Groveman,
C. Farris,
Bret Holguin,
A. Hughson,
David-Erick Lafontant,
C. Caspell-Garcia,
...
C. Coffey,
J. Mollon,
S. Hutten,
Kalpana M. Merchant,
R. Heym,
C. Soto,
B. Caughey,
U. Kang
|
7 |
2021 |
7
🐜
|
|
🦁
|
Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease
22 auth.
C. Caspell-Garcia,
T. Simuni,
D. Tosun-Turgut,
I-Wei Wu,
Yu. Zhang,
M. Nalls,
A. Singleton,
L. Shaw,
Ju-Hee Kang,
J. Trojanowski,
...
A. Siderowf,
C. Coffey,
Shirley Lasch,
D. Aarsland,
D. Burn,
L. Chahine,
A. Espay,
Eric D. Foster,
K. Hawkins,
I. Litvan,
I. Richard,
D. Weintraub
|
6 |
2017 |
6
🦁
|
|
🐜
|
Motor and nonmotor heterogeneity of LRRK2‐related and idiopathic Parkinson's disease
14 auth.
C. Marras,
R. Alcalay,
C. Caspell-Garcia,
C. Coffey,
P. Chan,
J. Duda,
M. Facheris,
R. Fernández-Santiago,
J. Ruiz‐Martinez,
T. Mestre,
...
R. Saunders-Pullman,
Claustre Pont-Sunyer,
E. Tolosa,
B. Warø
|
6 |
2016 |
6
🐜
|
|
🐜
|
Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls
10 auth.
B. Mollenhauer,
C. Caspell-Garcia,
C. Coffey,
Peggy Taylor,
L. Shaw,
J. Trojanowski,
...
A. Singleton,
M. Frasier,
K. Marek,
D. Galasko
|
6 |
2017 |
6
🐜
|
